Newsbenzinga
Glucotrack Stock Is Trending: Here's Why GCTK Jumped Over 80% After Hours
· Published
Article summary
GlucoTrack shares soar 80% after-hours as Lokahi Therapeutics signs first external glioblastoma licensing partnership with Innovate GBM.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…